Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion type Assertion NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_head.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion description "[Foxa1 protein expression was always observed in human prostate carcinomas, regardless of Gleason grade score, while Foxa2 was only detected in neuroendocrine small cell carcinomas and in some high Gleason score adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_provenance.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion evidence source_evidence_literature NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_provenance.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion SIO_000772 16001449 NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_provenance.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion wasDerivedFrom befree-20140225 NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_provenance.
- NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_assertion wasGeneratedBy ECO_0000203 NP350581.RAMEc_rPcT3xv22xv_HzgU2pFt_fXQSPqjBiZa6T9APtw130_provenance.